Wang Yongyu, Kuan Phillip J, Xing Chao, Cronkhite Jennifer T, Torres Fernando, Rosenblatt Randall L, DiMaio J Michael, Kinch Lisa N, Grishin Nick V, Garcia Christine Kim
Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Am J Hum Genet. 2009 Jan;84(1):52-9. doi: 10.1016/j.ajhg.2008.11.010. Epub 2008 Dec 18.
Idiopathic pulmonary fibrosis (IPF) is a lethal scarring lung disease that affects older adults. Heterozygous rare mutations in the genes encoding telomerase are found in approximately 15% of familial cases. We have used linkage to map another disease-causing gene in a large family with IPF and adenocarcinoma of the lung to a 15.7 Mb region on chromosome 10. We identified a rare missense mutation in a candidate gene, SFTPA2, within the interval encoding surfactant protein A2 (SP-A2). Another rare mutation in SFTPA2 was identified in another family with IPF and lung cancer. Both mutations involve invariant residues in the highly conserved carbohydrate-recognition domain of the protein and are predicted to disrupt protein structure. Recombinant proteins carrying these mutations are retained in the endoplasmic reticulum and are not secreted. These data are consistent with SFTPA2 germline mutations that interfere with protein trafficking and cause familial IPF and lung cancer.
特发性肺纤维化(IPF)是一种影响老年人的致命性瘢痕性肺病。在大约15%的家族性病例中发现了编码端粒酶基因的杂合罕见突变。我们利用连锁分析将一个患有IPF和肺腺癌的大家族中的另一个致病基因定位到10号染色体上一个15.7 Mb的区域。我们在编码表面活性蛋白A2(SP-A2)的区间内的一个候选基因SFTPA2中鉴定出一个罕见的错义突变。在另一个患有IPF和肺癌的家族中鉴定出SFTPA2的另一个罕见突变。这两个突变都涉及该蛋白高度保守的碳水化合物识别结构域中的不变残基,并预计会破坏蛋白质结构。携带这些突变的重组蛋白保留在内质网中,不会分泌。这些数据与干扰蛋白质运输并导致家族性IPF和肺癌的SFTPA2种系突变一致。